D. B. Ross

Sample size and the ethics of non-inferiority trials

Charles K. Cooper, J. Powers, Daphne Lin, 2005, The Lancet.

The FDA and the case of Ketek.

D. B. Ross, 2007, The New England journal of medicine.

The decline of science at the FDA has become unmanageable

D. B. Ross, 2023, BMJ.

Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.

J. Powers, Daphne Lin, D. B. Ross, 2004, Chest.

The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents.

J. Powers, E. Brittain, M. Goldberger, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sample size and the ethics of non-inferiority trials

Charles K. Cooper, J. Powers, Daphne Lin, 2005, The Lancet.